Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.51 |
| ▸ | GRPR | P30550 | 3/20 | 0.49 |
| ▸ | IL1RN | P18510 | 8/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 7/20 | 0.48 |
| ▸ | ERAP1 | Q9NZ08 | 5/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9331228 | 0.93 | REN (0.53) | RENGRPRIL1RNERAP2ERAP1 | |
| SCHEMBL9878964 | 0.92 | REN (0.51) | RENGRPRIL1RNERAP2ERAP1 | |
| SCHEMBL9331072 | 0.90 | REN (0.54) | RENGRPRIL1RNERAP2ERAP1 | |
| SCHEMBL9331193 | 0.88 | REN (0.55) | RENGRPRERAP2ERAP1CTSB | |
| SCHEMBL9331664 | 0.85 | MMP2 (0.53) | RENGRPR | |
| SCHEMBL9334625 | 0.82 | MMP2 (0.55) | RENGRPR | |
| SCHEMBL9879381 | 0.80 | MMP2 (0.51) | RENGRPRCTSBCTSK | |
| SCHEMBL10005187 | 0.79 | GRPR (0.53) | GRPRIL1RNERAP2ERAP1CTSB | |
| SCHEMBL11228028 | 0.79 | TACR1 (0.56) | RENTP53MAPTSMN1; SMN2CTSK | |
| SCHEMBL11228026 | 0.79 | TACR1 (0.56) | RENTP53MAPTSMN1; SMN2CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5068222-A | Polypeptides for treatment of cancer | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-11-26 | — | — | US | disclosed |